During the past decade, Hospital Universitario Infanta Sofía conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 2 clinical trials were completed, i.e. on average, 10.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Infanta Sofía" #1 sponsor was "PETHEMA Foundation" with 3 trials, followed by "Spanish Lung Cancer Group" with 3 trials sponsored, "Fundación GECP" with 2 trials sponsored, "Allena Pharmaceuticals" with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Infanta Sofía" #1 collaborator was "Celgene" with 3 trials as a collaborator, "Apices Soluciones S.L." with 1 trials as a collaborator, "Belgium and Luxembourg Gynaecological Oncology Group" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Hospital Clinic of Barcelona" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Infanta Sofía" are "Multiple Myeloma" (3 trials), "Covid19" (2 trials), "Lung Cancer" (2 trials), "Thrombosis" (2 trials) and "Anticoagulant Therapy" (1 trials). Many other conditions were trialed in "Hospital Universitario Infanta Sofía" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Infanta Sofía" are "Drug" (17 trials), "Combination Product" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Dexamethasone" (2 trials), "Melphalan" (2 trials), "ALLN-177" (1 trials) and "Apixaban 5 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Infanta Sofía" are 20 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Universitario Infanta Sofía". undefined are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Hospital Universitario Infanta Sofía, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Infanta Sofía, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".